Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (3)
Type
Type
Guidance (109)
NICE advice (14)
Quality standard (9)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (1)
Clinical guidelines (14)
Diagnostics guidance (3)
Highly specialised technologies guidance (4)
Interventional procedures guidance (17)
Medical technologies guidance (10)
NICE guidelines (20)
Public health guidelines (4)
Social care guidelines (3)
Technology appraisal guidance (55)
Advice programme
Advice programme
Evidence summaries (2)
Medtech innovation briefings (12)
Apply filters
Showing 76 to 100 of 132
Sort by
Date
Title
Apply sorting
Last updated date between 1/12/2021 and 30/6/2022
Remove Last updated date between 1/12/2021 and 30/6/2022 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection
TA761
19 January 2022
19 January 2022
Otitis media (acute): antimicrobial prescribing
NG91
28 March 2018
11 March 2022
Palforzia for treating peanut allergy in children and young people
TA769
2 February 2022
2 February 2022
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria
TA778
9 March 2022
9 March 2022
Pelvic floor dysfunction: prevention and non-surgical management
NG210
9 December 2021
9 December 2021
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma
TA766
2 February 2022
2 February 2022
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies
TA772
23 February 2022
23 February 2022
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer
TA801
29 June 2022
29 June 2022
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer
TA770
9 February 2022
9 February 2022
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis
IPG720
9 March 2022
9 March 2022
Peristeen Plus transanal irrigation system for managing bowel dysfunction
MTG36
23 February 2018
6 June 2022
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndrome
IPG724
18 May 2022
18 May 2022
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea
TA776
9 March 2022
9 March 2022
Ponesimod for treating relapsing–remitting multiple sclerosis
TA767
2 February 2022
2 February 2022
PredictSURE IBD and IBDX to guide treatment of Crohn's disease
DG45
23 February 2022
23 February 2022
Preterm labour and birth
NG25
20 November 2015
10 June 2022
Prontosan for treating acute and chronic wounds
MTG67
8 March 2022
8 March 2022
Prostate cancer
QS91
11 June 2015
30 December 2021
Prostate cancer: diagnosis and management
NG131
9 May 2019
15 December 2021
Reducing sexually transmitted infections
NG221
15 June 2022
15 June 2022
Rehabilitation after traumatic injury
NG211
18 January 2022
18 January 2022
Romosozumab for treating severe osteoporosis
TA791
25 May 2022
25 May 2022
SecurePort IV tissue adhesive for use with percutaneous catheters
MIB288
15 March 2022
15 March 2022
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care
MTG65
27 January 2022
27 January 2022
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer
TA760
12 January 2022
12 January 2022
Previous page
1
2
3
Current page
4
5
6
Page
4
of
6
Next page
Results per page
10
25
50
All
Back to top